Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-07 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |